Abattis Bioceuticals (PK) Stock Price - ATTBF

0.0099
0.00084 (9.27%)
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Abattis Bioceuticals Corporation (PK) ATTBF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00084 9.27% 0.0099 0.009 0.0112 0.009 0.00906 16:30:10
Bid Price Ask Price Spread Spread % News
0.009 0.0105 0.0015 14.29% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
23 81,343 $ 0.009777 $ 795 1,037,788 0.0025 - 0.069
Last Trade Time Type Quantity Stock Price Currency
15:51:11 1,800 $ 0.0099 USD

Abattis Bioceuticals (PK) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.23M 427.11M $ -7.63M - - 91.13M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
28.60k $ - 0.00% - -

more financials information »

Abattis Bioceuticals (PK) News

Loading Messages....

Latest ATTBF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ATTBF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0090.01280.0080.0102027439,3600.000910.0%
1 Month0.02270.02270.0030.0135324461,010-0.0128-56.39%
3 Months0.0090.023150.0030.00937611,045,1620.000910.0%
6 Months0.0270.0340.0030.0114771700,359-0.0171-63.33%
1 Year0.0550.0690.00250.0224857651,705-0.0451-82.0%
3 Years0.1660.74440.00250.169042931,533-0.1561-94.04%
5 Years0.161.000.00250.1589195650,625-0.1501-93.81%

Abattis Bioceuticals (PK) Description

Abattis is a life sciences and biotechnology company which aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. The Company is also seeking to acquire exclusive intellectual property rights to agricultural technologies to be employed in extraction and processing of botanical ingredients and compounds. The Company follows strict standard operating protocols, and adheres to the applicable laws of Canada and foreign jurisdictions.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.